Michael A. Metzger, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 32,462 shares at $25.29 ($821K) on 2022-10-06, disclosed to the SEC on 2022-10-07.
Open-market sale of $821k SNDX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.29 | 16,231 | $410K | 50.0% |
| 2 | $25.29 | 16,231 | $410K | 50.0% |
| Total | $25.29 avg | 32,462 | $821K | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |